Clinical trial

Quetiapine in Patients With Bipolar and Alcohol Abuse/Dependence

NCT00223249 · University of Texas Southwestern Medical Center, Other · Completed

Key facts

NCT number NCT00223249
Title Quetiapine in Patients With Bipolar and Alcohol Abuse/Dependence
Official title A Randomized, Double-Blind, Placebo-Controlled Add-On Trial of Quetiapine in Patients With Bipolar Disorder and Alcohol Abuse/ Dependence.
Lead sponsor University of Texas Southwestern Medical Center, Other
Status Completed
Phase Phase 4
Study type Interventional
Conditions Bipolar Disorder, Alcohol Abuse/Dependence
Intervention type Drug
Interventions Quetiapine
Enrollment 115
Start date Nov 1, 2002
Primary completion Aug 1, 2004
Completion Aug 1, 2004
First posted Sep 22, 2005
Last update posted Apr 4, 2016
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies